The dietary intake of soybean βCG reduces serum TG levels and visceral fat in hyperlipidemic humans [118] and exerts anti-obesity effects by promoting postprandial circulating levels of fibroblast growth factor 21 (FGF21) in mice [119]. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.